Publications by authors named "Mark Brunvand"

Claim this Profile
S
Safety and efficacy of polatuzumab vedotin + obinutuzumab for relapsed/refractory non-Hodgkin lymphomas: A phase IB/II study.
Tycel Phillips, Mark Brunvand, Andy I Chen, James Essell, Annalisa Chiappella

Am J Hematol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete remission with romidepsin in a patient with T-cell acute lymphoblastic leukemia refractory to induction hyper-CVAD.
Mark W Brunvand, John Carson

Hematol Oncol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of the Anti-CD22 Antibody-Drug Conjugate Pinatuzumab Vedotin with/without Rituximab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma.
Ranjana H Advani, Daniel Lebovic, Andy Chen, Mark Brunvand, Andre Goy

Clin Cancer Res· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of PRO131921, a novel anti-CD20 monoclonal antibody in patients with relapsed/refractory CD20+ indolent NHL: correlation between clinical responses and AUC pharmacokinetics.
Carla Casulo, Julie M Vose, William Y Ho, Brad Kahl, Mark Brunvand

Clin Immunol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amyloidosis relapsing after autologous stem cell transplantation treated with bortezomib: normalization of detectable serum-free light chains and reversal of tissue damage with improved suitability for transplant.
Mark W Brunvand, Mitchell Bitter

Haematologica· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship of reconstituted adaptive and innate cytomegalovirus (CMV)-specific immune responses with CMV viremia in hematopoietic stem cell transplant recipients.
Michelle A Barron, Dexiang Gao, Kathryn L Springer, Julie A Patterson, Mark W Brunvand

Clin Infect Dis· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease.
David M Hockenbery, Scott Cruickshank, Timothy C Rodell, Ted Gooley, Friedrich Schuening, Mark Brunvand

Blood· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy.
Francis J Giles, Roberto Rodriguez, Daniel Weisdorf, John R Wingard, Paul J Martin, Mark M Brunvand

Leuk Res· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase III, randomized, double-blind, placebo-controlled, multinational trial of iseganan for the prevention of oral mucositis in patients receiving stomatotoxic chemotherapy (PROMPT-CT trial).
Francis J Giles, Carole B Miller, David D Hurd, John R Wingard, Thomas R Fleming, Mark M Brunvand

Leuk Lymphoma· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis